Introducing the new AltIndexLearn more
$5.2B 1.6%Beat EPS +1.0%
Total revenue, Q1 '26 (USD).

Did Boston Scientific Beat Earnings?

Boston Scientific (BSX) reported Q1 '26 revenue of $5.2B, up 11.6% year-over-year, with reported EPS of $0.80. That topped the $0.79 analyst estimate by 1.0% — an earnings beat.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Boston Scientific’s job postings, web traffic, and employee business outlook. See the full BSX stock analysis or the earnings calendar for upcoming reports.

BSX Earnings Surprise History (EPS vs. Estimate)

QuarterEstimated EPSReported EPSSurprise
Q1 '26 $0.79 $0.80 Beat +1.0%
Q4 '25 $0.78 $0.80 Beat +2.6%
Q3 '25 $0.71 $0.75 Beat +5.6%
Q2 '25 $0.73 $0.75 Beat +2.7%
Q1 '25 $0.67 $0.75 Beat +11.9%
Q4 '24 $0.66 $0.70 Beat +6.1%

Boston Scientific Quarterly Financial Trends (USD)

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Revenue4.12B4.21B4.56B4.66B5.06B5.07B5.29B5.2B
Gross margin62.7%62.9%58.6%63.3%67.7%69.9%74.5%69.4%
Operating margin18.1%16.0%12.9%19.2%16.2%20.7%22.8%20.6%
Net income324M469M566M674M793M755M668M1.34B
Net margin7.9%11.1%12.4%14.5%15.7%14.9%12.6%25.7%
EPS$0.62$0.63$0.70$0.75$0.75$0.75$0.80$0.80

Boston Scientific Earnings Trend Analysis

Over the eight quarters from Q2 '24 to Q1 '26, Boston Scientific’s quarterly revenue moved from $4.12B to $5.2B. Net margin expanded from 7.9% to 25.7%, against a 69.4% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Boston Scientific has beaten Wall Street EPS estimates in 8 of its last 8 reported quarters.

When Is Boston Scientific’s Next Earnings Date?

Boston Scientific reports earnings on a quarterly schedule. Its most recent report covered Q1 '26. For the confirmed upcoming date — and every other company reporting soon — see the BSX earnings calendar.

Frequently Asked Questions: Boston Scientific Earnings

Boston Scientific's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Boston Scientific reported Q1 '26 EPS of $0.80 on revenue of $5.2B (+11.6% YoY). Boston Scientific beat estimates, reporting $0.80 vs. the $0.79 estimate.

Boston Scientific reported Q1 '26 revenue of $5.2B, up 11.6% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the BSX AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.